A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures
The Journal of Infectious Diseases · 18.10.2023 · 228 (Supplement_6) · S398-S413
DOI: 10.1093/infdis/jiad193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 18.10.2023. Verfasst von Richard J Kuhn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Flavivirus, Flavivirus Infections, Zika Virus, Vaccines. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Flaviviruses are a genus within the Flaviviridae family of positive-strand RNA viruses and are transmitted principally through mosquito and tick vectors. These viruses are responsible for hundreds of millions of human infections worldwide per year that result in a range of illnesses from self-limiting febrile syndromes to severe neurotropic and viscerotropic diseases and, in some cases, death. A vaccine against the prototype flavivirus, yellow fever virus, has been deployed for 85 years and is highly effective. While vaccines against some medically important flaviviruses are available, others have proven challenging to develop. The emergence and spread of flaviviruses, including dengue virus and Zika virus, demonstrate their pandemic potential. This review highlights the gaps in knowledge that need to be addressed to allow for the rapid development of vaccines against emerging flaviviruses in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Purdue University, West Lafayette, Indiana, USA.
- Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, Indiana, USA.
- Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, Texas, USA.
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California Berkeley, Berkeley, California, USA.
ORCID-Profile: Richard J Kuhn
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Kuhn, R. J., Barrett, A. D. T., Desilva, A. M., Harris, E., Kramer, L. D., Montgomery, R. R., Pierson, T. C., Sette, A., & Diamond, M. S. (2023). A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures. The Journal of Infectious Diseases, 228(Supplement_6), S398-S413. https://doi.org/10.1093/infdis/jiad193
Vancouver
Kuhn RJ, Barrett ADT, Desilva AM, Harris E, Kramer LD, Montgomery RR, et al. A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures. The Journal of Infectious Diseases. 2023;228(Supplement_6):S398-S413. doi:10.1093/infdis/jiad193
BibTeX
@article{Kuhn2023,
author = {Kuhn, Richard J and Barrett, Alan D T and Desilva, Aravinda M and Harris, Eva and Kramer, Laura D and Montgomery, Ruth R and Pierson, Theodore C and Sette, Alessandro and Diamond, Michael S},
title = {A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {228},
number = {Supplement_6},
pages = {S398--S413},
doi = {10.1093/infdis/jiad193}
}
EUVIMED